Inter-Laboratory Comparability of Clinical Chemistry Testing: A New Perspective by Quartey, Perez et al.
 International Journal of Sciences: 
Basic and Applied Research 
(IJSBAR) 
 
ISSN 2307-4531 
(Print & Online) 
 
http://gssrr.org/index.php?journal=JournalOfBasicAndApplied 
--------------------------------------------------------------------------------------------------------------------------- 
196 
 
Inter-Laboratory Comparability of Clinical Chemistry 
Testing: A New Perspective 
Perez Quartey
a
*, Ruth Anokye
b
, Michael Frimpong
c
 
a,b,c
Department of Medical Laboratory Technology, Garden City University College, Kenyase, Ghana 
a
Email: quartey.perez@gcuc.edu.gh 
b
Email: obaaabrafi29@gmail.com 
c
Email: mfrimpongboadu@gmail.com 
Abstract 
Background/Aim: Existing external quality assurance proficiency testing may not reflect routine „real-world‟ 
daily testing proficiency. The overall aim of the study was to conduct an inter-laboratory comparability testing 
of some routinely measured clinical chemistry analytes by selected private medical laboratories using the 
mentor-adept approach. Methodology: Aliquots of freshly separated plasma from a single individual (1ml) each 
were sent to each of the selected labs and a Teaching hospital for same-day testing. All samples were sent as 
„„blinded-samples‟‟ (labelled with anonymous names, ages and attached lab request forms with clinical 
diagnoses) so that they would be tested as real patient samples. Results: All the labs met the acceptability 
criteria range for both the z-score and Precision Index. However, many of the labs had their total analytical 
errors for the tests outside the allowable total error ranges with both European and CLIA recommendations. 
Conclusion: There are relative similarities in the z-score (inter-laboratory bias) and Precision Index (inter-
laboratory precision) among the labs. However, many of the labs did not meet recommended analytical goals for 
total analytical errors on individual samples run in a day. In the light of the findings, it is highly recommended 
that though laboratories should be aware of conduction of periodic external quality assurance exercises, such 
exercises should be done using “blinded-samples” as utilized in this current study without prior notification of 
the day and time of testing. 
Keywords: Inter-laboratory; Mentor-adept; External Quality Assurance; z-score; Precision Index; Total 
Analytical Error. 
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1.  Introduction  
Quality of clinical chemistry testing is very critical in diagnostic and overall patient assessment by expressing 
reliability in testing results. Clinical chemistry testing presents as a very critical aspect of general laboratory 
testing and it takes highly automated measurement methods and systems, combined with advanced information 
technologies to accomplish this all-important task [1]. The overall uncertainty of the high-volume measurement 
methods in clinical chemistry has decreased substantially in recent decade tough bias still remains as a 
significant challenge. A key component of laboratory quality management system is Quality Assurance (QA) 
which includes both Internal Quality control (done on regular daily basis) and External Quality Assurance 
(EQA). EQA is done periodically, in collaboration with a higher laboratory authority through Proficiency 
Testing (PT) or Inter-lab comparability (ILC) testing. with PT being the ideal method of choice in evaluating 
laboratory performance [2, 3, 4, 5]. In cases where for some reasons there is lack of proficiency testing schemes, 
inter-laboratory comparisons (ILCs) are preferred by accreditation bodies [5]. Typical method of assessment of 
ILC results have been described with standard statistical protocols [4, 6, 7] with the use of „reference‟ materials 
prepared by the QA provider for measurements. When it is not possible to apply this, the mentor-adept approach 
of inter-laboratory comparison may be used [1]. Measurement results of analytes from the expert (mentor-lab), 
„„considered‟‟ to be devoid of bias [1] are compared with that of the participating laboratories. The inter-
laboratory analysis of the results is done using recommended statistical methods. Statistically stringent or robust 
analysis „„consensus‟‟ values calculated from participant results are recommended for the estimation of an 
assigned value and are typically used for calculating the z-score, precision index (PI) and Total analytical error 
(TE) [4, 5, 6, 8]. Presently, we are not aware of any external quality assurance exercise conducted for clinical 
chemistry testing by medical laboratories in Ghana. 
1.1. Aim of the Study 
The overall aim of the study was to conduct an inter-laboratory comparability testing of some routinely 
measured clinical chemistry analytes by some selected private medical labs in Kumasi (the second largest city in 
the country) using the mentor-adept approach of performance evaluation. 
2. Materials and Methods 
2.1. Ethical consideration  
Approval for the research was received from the Kwame Nkrumah University of Science and Technology 
Research Committee. 
2.2. Study design 
Using the Mentor-Adept approach, the cross-sectional study was conducted on six (6) selected private 
laboratories. 
2.3. Mentor lab 
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Komfo Anokye Teaching Hospital Chemical Pathology laboratory. 
2.4. Adept-labs 
Six (6) selected private labs in the Kumasi metropolis. The locations of two of the labs are relatively farther 
away from the mentor-lab whiles the other four are in the vicinity of the mentor-lab. All labs were assigned 
alphabetical codes for ethical anonymity.   
2.5. Study protocol and procedures 
After thoroughly explaining the aim, objectives and procedures of the study, venous blood was collected from a 
single healthy donor. Freshly separated plasma was aliquoted into clean eppendorf tubes. Seven (7) of the 1ml 
plasma aliquots were sent to each of the selected labs for same-day testing and reporting. All samples were sent 
as „„blinded-samples‟‟ (labeled with anonymous names, ages and attached lab request forms with clinical 
diagnoses) so that they would be tested as real patient samples.   
2.6. Measurements 
Sodium, Potassium, Urea, Creatinine, Total Cholesterol, HDL, Triglycerides. 
2.7. Data analysis 
Comparability of precision, accuracy and total analytical error were assessed using standard lab quality 
assurance statistical methods. Inter-laboratory comparability of analytical bias was assessed by calculation of 
„„Consensus-based‟‟ Standard Deviation Index (z-score), using robust calculation involving exclusion of outlier 
results [4]. 
        
                           
                            
 
Classification criteria: 
0 to ±1 = Satisfactory 
>1 to 2 = Acceptable 
± > 2 = Unacceptable 
Inter-laboratory comparability of imprecision was assessed calculation of „„Consensus-based‟‟ Precision Index 
[4]. 
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Classification criteria: 
0 to ±1 = Satisfactory 
>1 to 2 = Acceptable 
± > 2 = Unacceptable 
Inter-laboratory comparability of overall analytical performance was assessed with total analytical error and 
comparing it with two recommended specifications of allowable total error (TEa) [4, 9, 10].  
The following methods were used in evaluation of performance:  
a. Total analytical error calculated as 1.65 x CV of lab   % bias, where % bias is; 
                      
              
       
This error is compared with European recommended allowable total error for each analyte by Ricos and his 
colleagues 2014 [9].   
b. Lab means compared with CLIA [10] recommended allowable total error calculated as mentor mean 
(target value) ± recommended % bias. 
3. Results  
3.1. General characteristics, Z-score and PI scores of the labs 
The general characteristics, Z-scores and PI-scores of the participant labs are shown on results of the z-score 
distributions in the participating labs are illustrated on table 1, 2 and 3 respectively. The results showed that all 
the mean results of tests were within the acceptability criteria range (± 2 standard deviation points from the 
consensus mean). All the mean results of Lab A were in the satisfactory range. The mean results that moved 
from the satisfactory range into the acceptable range were urea and creatinine for Lab B, sodium and creatinine 
for Lab C, HDL for Labs D and F, and both urea and triglyceride for Lab E. Additionally, all the participant labs 
met the acceptability criteria for precision index (± 2). A detailed analysis however showed that the PI moved 
from the satisfactory range to the acceptable range for sodium (Lab B) potassium (Lab C) and both LDL and 
HDL for Lab D. 
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Table 1: General Characteristics of the study laboratories. 
Lab Sodium Potassium Urea Creatinine Cholesterol HDL Triglycerides 
Mentor-lab 149.2 ± 0.36 4.2 ± 0.11 2.25 ± 0.02 71.7 ± 1.53 3.22 ± 0.12 0.92 ± 0.01 1.14 ± 0.01 
A 146.7 ± 2.18 4.1 ± 0.08 3.8 ± 0.42 75.5 ± 7.13 3.77 ± 0.27 1.04 ± 0.16 1.61 ± 0.28 
B 121.5 ± 21.85 3.9 ± 0.31 2.5 ± 0.01 137.6 ± 1.00 3.21 ± 0.01 0.95 ± 0.01 1.34 ± 0.03 
C 105.1 ±1.76 3.5 ± 0.43 3.8 ± 0.48 71.4 ± 1.55 3.91 ± 0.11 1.13 ± 0.01 1.78 ± 0.06 
D 145.5 ± 0.86 4.1 ± 0.02 3.6 ± 0.71 87.9 ± 10.31 4.87 ± 0.43 1.83 ± 0.46 1.73 ± 0.10 
E 137.9 ± 1.35 3.8 ± 0.10 5.3 ± 0.05 80.8 ± 16.19 3.79 ± 0.41 1.37 ± 0.30 0.96 ± 0.05 
F 143.3 ± 1.60 4.3 ± 0.30 4.7 ± 0.17 60.9 ± 3.12 3.80 ± 0.30 0.69 ± 0.07 1.27 ± 0.08 
Consensus Mean 133.3 ± 17.55 4.0 ± 0.34 4.0 ± 0.96 85.7 ± 26.18 3.88 ± 0.57 1.17 ± 0.43 1.49 ± 0.10 
Results are expressed as mean ± SD in mmol/l. 
Table 2: Z-scores of the study labs 
Lab Sodium Potassium Urea Creatinine Cholesterol HDL Triglycerides 
A 0.8 0.3 -0.2 0.4 -0.2 -0.3 0.4 
B -0.7 -0.3 -1.6
α
 2.0
 α
 -1.2 -0.5 -0.5 
C -1.6
 α
 -1.5
 α
 -0.2 -0.6 0.1 -0.1 0.9 
D 0.7 0.3 -0.4 0.1 1.7 1.5
 α
 0.7 
E 0.3 0.6 1.4
 α
 0.2 -0.2 0.5 -1.6
 α
 
F 0.6 0.9 0.7 1.0 -0.1 -1.1
 α
 -0.7 
Scores with no superscript means values are in satisfactory range (less than ± 1.0); lab means with superscript (
α
) means values 
are in acceptable range (± 1.1 – 2.0). 
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Table 3: Precision Indexes (PI) of the study labs 
LAB Sodium Potassium Urea Creatinine Cholesterol HDL Triglycerides 
A 0.1 0.2 0.02 0.3 0.5 0.4 0.8 
B 1.3
 α
 0.9 0.4 0.04 0.2 0.02 0.1 
C 0.1 1.3
 α
 0.5 0.1 0.02 0.02 0.2 
D 0.05 0.1 0.7 0.4 0.8 1.1
 α
 0.3 
E 0.1 0.3 0.1 0.6 0.7 0.7 0.2 
F 0.1 0.9 0.2 0.1 0.5 0.2 0.2 
 
Scores with no superscript means PI values are in satisfactory range (less than ± 1.0); Scores with superscript (
α
) means PI values are in acceptable range  
(± 1.1 – 2.0). 
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Table 4: Total analytical errors of the study labs compared by the European recommendations. 
Analyte Lab A Lab B Lab C Lab D Lab E Lab F TEa (%) 
Sodium 
CV (%) 
%Bias 
TE (%) 
 
1.5 
1.7 
4.2
 β
 
 
18.0 
18.6 
48.3
β
 
 
1.7 
29.6 
32.4
 β
 
 
0.6 
2.5 
3.5
 β
 
 
1.0 
7.6 
9.3
 β
 
 
1.1 
4.0 
5.8
 β
 
 
 
 
1.0 
Potassium 
CV (%) 
%Bias 
TE (%) 
 
2.0 
2.4 
5.7
 β
 
 
7.9 
7.1 
20.1
 β
 
 
12.3 
16.7 
40.0
 β
 
 
0.5 
2.4 
3.2 
 
2.6 
9.5 
13.8
 β
 
 
6.9 
2.4 
13.8
 β
 
 
 
 
5.61 
Urea 
CV (%) 
%Bias 
TE (%) 
 
11.1 
68.9 
87.2
 β
 
 
0.4 
11.1 
11.7 
 
12.6 
68.9 
96.3
 β
 
 
19.7 
56.5 
89.0
 β
 
 
0.9 
130.4 
131.5
 β
 
 
3.6 
104.3 
110.2
 β
 
 
 
 
15.55 
Creatinine 
CV (%) 
%Bias 
TE (%) 
 
9.4 
5.3 
20.8
 β
 
 
0.7 
92.0 
93.2
 β
 
 
2.2 
0.4 
4.0 
 
11.7 
22.6 
41.9
 β
 
 
20.0 
12.7 
45.7
 β
 
 
5.1 
15.1 
23.5
 β
 
 
 
 
8.87 
Cholesterol 
CV (%) 
%Bias 
TE (%) 
 
7.2 
17.1 
29.0
 β
 
 
0.3 
0.3 
0.8 
 
2.8 
21.4 
26.0
 β
 
 
8.8 
51.2 
65.7
 β
 
 
10.8 
17.7 
35.5
 β
 
 
7.9 
18.0 
31.0
 β
 
 
 
 
9.01 
HDL 
CV (%) 
%Bias 
TE (%) 
 
15.4 
3.3 
28.7
 β
 
 
1.1 
3.2 
5.0 
 
0.9 
22.8 
24.3
 β
 
 
25.1 
98.9 
140.3
 β
 
 
21.9 
48.9 
85.0
 β
 
 
10.1 
25.0 
41.6
 β
 
 
 
 
11.63 
Triglycerides 
CV (%) 
%Bias 
TE (%) 
 
17.4 
41.2 
69.9
 β
 
 
2.2 
17.5 
21.1 
 
3.4 
56.1 
61.7
 β
 
 
5.8 
51.7 
61.3
 β
 
 
5.2 
18.8 
27.4
 β
 
 
6.3 
11.4 
21.8 
 
 
 
25.99 
TEa: Allowable total error; 
β: 
Total analytical error beyond the allowable total error range for the analyte. 
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Table 5: Total analytical errors (TE) of the study labs compared by CLIA 2019 recommendations. 
Analyte (mmol/l) Lab A Lab B Lab C Lab D Lab E Lab F Mentor- lab mean TEa limits 
Sodium 146.7 121.5
 β
 105.1
 β
 145.5 137.9 
β
 143.3
 β
 149.2 145 - 153 
Potassium 4.1 3.9 3.5
 β
 4.1 3.8
 β
 4.3 4.2 3.9 - 4.5 
Urea 3.8
 β
 2.5 3.8
 β
 3.6
 β
 5.3 
β
 4.7
 β
 2.3 2.09 - 2.51 
Creatinine 75.5 137.6
 β
 71.4 87.9
 β
 80.8
 β
 60.9
 β
 70.0 63.0 – 77.0 
Cholesterol 3.8
 β
 3.2 3.9
 β
 4.9
 β
 3.8
 β
 3.8
 β
 3.21 2.89 – 3.53 
HDL 1.04 0.95 1.13
 β
 1.83
 β
 1.37
 β
 0.69
 β
 0.92 0.74 – 1.10 
Triglycerides 1.61
 β
 1.3 1.8
 β
 1.70 
β
 0.96
 β
 1.27 1.14 0.97 – 1.31 
TEa: Allowable total error (CLIA, 2019), 
β: 
Total analytical error beyond the allowable total error range for the analyte. 
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Table 6: Comparison of overall performance of the study labs based on European and CLIA total error 
specifications. 
Study Lab European recommendation CLIA recommendation 
Lab A 0 (0.0%) 4 (57.1%) 
Lab B 4 (57.1%) 5 (71.4%) 
Lab C 1 (14.3%) 1 (14.3%) 
Lab D 1 (14.3%) 2 (28.6%) 
Lab E 0 (0.0%) 0 (0.0%) 
Lab F 2 (28.6%) 2 (28.6%), 
 
Results are expressed as number (%) of analytes that passed allowable total errors by the recommended 
specifications. 
Overall analytical performance of the study labs 
The overall performance was calculated in percentage points of the number of analyte measurements that passed 
the recommended specifications out of the total number of measured analytes. The overall performance as 
illustrated in tables 4, 5 and 6 showed that many of the labs had their total analytical errors for the tests outside 
the allowable total error ranges with only Lab B scoring 4 correct analytical points (57.1%). Labs C, D and F 
scored 1(14.3%) correct analytical point whilst Labs A and E did not score any point; with the use of the 
European classification. In comparison to CLIA recommendation however, Lab A scored 4 (57.1%), Lab B 
scored 5 (71.4%), Lab C scored 1 (14.3%), Labs D and Lab F scored 2 (28.6%), whilst lab E did not score any 
point. 
4. Discussion 
Laboratory external quality assessment describes a method or process that allows testing conducted by a 
laboratory to be compared to that of a source outside the laboratory which may be a peer group of laboratories 
or a reference laboratory. For accrediting bodies and regulatory agencies, participation in EQA program 
provides objective evidence of the quality of testing of patients‟ specimens [9,10]. In general, there is limited 
data on EQA of clinical chemistry testing in Ghana. Presently, there is no oversight body that organizes External 
Quality assurance tests of clinical chemistry in Ghana. This is the first study to report on the inter-laboratory 
comparability of clinical chemistry testing in Ghana, using the mentor-adept approach. Without participation in 
high-quality inter-laboratory comparability program, a laboratory may be unaware of periodic gradual or sudden 
changes in performance of the testing system that may be caused by factors such as change in reagents or 
calibrators, standardization changes, or instrument software changes. Participation in an inter-laboratory 
comparability program can therefore offer awareness of shifts and trends and help verify the reliability and 
quality of testing. An inter-laboratory program can also increase the confidence of laboratories in participation 
in proficiency testing surveys.  
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4.1. Key Findings of the Current Study 
This study typically assessed, the consensus-based z-score, precision index, and total analytical error of the 
selected laboratories in some routinely measured clinical chemistry tests [4, 8, 11, 12]. This study presents the 
likely events of the „„real-life‟‟ daily results presented to patients and requesting physicians alike when samples 
are handled as routine patient samples for laboratory analysis and not as samples for an external quality 
assurance work. In the current study, the results showed that all the mean test results (z-scores) and the Precision 
indexes of the labs were within the acceptability criteria range (± 2). The exclusion of individual laboratory 
results outliers for calculation of the „„consensus or peer-group‟‟ mean and standard deviation implies that 
interpretation of the z-score and PIs typically relies on the statistical assumption that the results are normally 
distributed and therefore introduces similarities. These parameters do not give an indication of the laboratory‟s 
analytical performance but rather an idealized performance of the study group, though they are useful in 
identifying very questionable analytical deficiencies in the event of a participant lab having a score for an 
analyte outside the acceptable range. Thus, it has been advocated that in a single round of proficiency testing, 
providers, participants and end-users should avoid classification and ranking of laboratories based on these 
scores [13, 14,15].  The comparison of total analytical error for the analytes by the study labs using both 
European and CLIA recommendations showed that many of the labs had their total analytical errors for the tests 
outside the allowable total error ranges. A detailed comparison showed that most of the study labs failed with 
the use of European recommendations as compared to CLIA recommendations. These discrepancies need 
further investigations for reconciliation and harmonization in the light of differences in specifications and 
recommendations.   
4.2. Key Points of Interest 
Anytime a sample is sent to the lab, the requesting physician or patient does not care about the measurement 
system, testing method or competency of the medical lab technologist doing the testing. All they expect is a 
reliable result, irrespective of whatever was primarily used to produce the results. For example, a client who 
walks into a lab with a plasma potassium level of 3.4 mmol/l, irrespective of whatever system, method, time of 
testing or lab personnel expects a report result within an acceptable range (as close enough to 3.4 mmol/l). 
External quality assurance typically involves an accredited scheme provider preparing reference materials and 
sending them to the participating laboratories for measurements [16,17]. The results from the participating labs 
are then returned to the scheme provider for analysis and feedback reported to the participating labs. The whole 
process of the proficiency testing is done with the conscious awareness of the participating labs of their 
involvement in an EQA exercise. External quality assurance programs like proficiency testing and inter-
laboratory comparison provide substantial information to measure overall testing performance. However, they 
do not give a measure of the daily accuracy, reproducibility and overall reliability of individual testing. In our 
view, EQA surveys may merely provide a snapshot in time and should not be used as a substitute for daily 
quality. When EQA is conducted with the conscious awareness of the participating labs that the testing is being 
carried out as part of a formal EQA program, there is a strong likelihood of bias in adhering to strict internal 
quality control standards with the sole aim of achieving good results. “Acceptable” performance in the EQA 
testing may therefore not reflect or guarantee testing reliability on individual samples run as real daily work. 
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Our main issue was to find out the comparability of test results as run by the labs in their real daily testing. 
Therefore, in the present study no contact was made with the testing personnel to identify any instrumental, 
methodological or internal quality assurance differences between the labs included in the study. The results of 
the labs were therefore considered as true results that they would have reported, and dispatched to clients on a 
„„real-life‟‟ basis. 
4.3. Key Strengths of the Current Study 
1. All samples were sent to the selected labs as “blinded-patient samples”. All samples were labelled with 
anonymous patient names, ages, gender and attached with corresponding request forms with different 
clinical diagnoses;  
2. All the selected labs performed testing without a conscious awareness of any inter-laboratory 
comparability exercise and all results were collected as „„normal patient‟‟ results as routinely 
dispatched by the labs. All these show that the results give the most likely test reporting that would 
have been produced by the labs as part of their routine daily runs. 
5. Conclusion  
This study reports the first assessment of inter-laboratory comparability of clinical chemistry testing using the 
mentor-adept approach in Ghana. The study identified that there are relative similarities in the z-score (inter-
laboratory bias) and Precision Index (inter-laboratory precision) among the selected labs. However, there are 
considerable variations in the total analytical errors of testing. The differences in total analytical error as 
compared to recommended allowable total error criteria may be a better indication of overall analytical 
performance. In general, many of the laboratories did not meet the recommended analytical goals on individual 
samples run in a day. These observed analytical deficiencies require critical investigation into the internal 
quality assurance practices of laboratories in the country. 
5.1. Recommendations  
It is highly recommended that though laboratories should be aware of conduction of periodic external quality 
assurance exercises, such exercises should be done using “blinded-samples” without prior notification of the day 
and time of testing as utilized in this current study. 
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